Balancing potential risks and benefits of adjunctive use of aripiprazole with risperidone for the treatment of schizophrenia

Reply to Dr Deng et al

Hiroyuki Uchida, David C. Mamo

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)136-137
Number of pages2
JournalJournal of Clinical Psychopharmacology
Volume31
Issue number1
DOIs
Publication statusPublished - 2011 Feb

Fingerprint

Risperidone
Schizophrenia
Aripiprazole

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

@article{f862ac40ac714eac8fa426d0a0460a87,
title = "Balancing potential risks and benefits of adjunctive use of aripiprazole with risperidone for the treatment of schizophrenia: Reply to Dr Deng et al",
author = "Hiroyuki Uchida and Mamo, {David C.}",
year = "2011",
month = "2",
doi = "10.1097/JCP.0b013e318207751e",
language = "English",
volume = "31",
pages = "136--137",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Balancing potential risks and benefits of adjunctive use of aripiprazole with risperidone for the treatment of schizophrenia

T2 - Reply to Dr Deng et al

AU - Uchida, Hiroyuki

AU - Mamo, David C.

PY - 2011/2

Y1 - 2011/2

UR - http://www.scopus.com/inward/record.url?scp=78651315475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651315475&partnerID=8YFLogxK

U2 - 10.1097/JCP.0b013e318207751e

DO - 10.1097/JCP.0b013e318207751e

M3 - Article

VL - 31

SP - 136

EP - 137

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 1

ER -